Amara Raja Energy & Mobility Ltd (ARE&M) Q1 FY27 Earnings Call: Guides Full Cost Recovery by Q3, Capex Guided at Rs.1,700 Crore

Cofacto Research Published August 11, 2026 6 min read

Amara Raja Energy & Mobility Ltd held its Q1 FY27 earnings call on August 10, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Headline financials for the June quarter

  • Consolidated revenue of Rs.4,215 crores — grew 24% YoY in Q1 FY 2026-2027, driven by lead-acid growth and a sharp ramp in the new energy business.
  • Lead-acid battery business contributed 95% of revenue — expanding 22% YoY in Q1 FY 2026-2027, while the new energy segment reached Rs.209 crores (+>70% YoY).
  • Standalone EBITDA margin at 10.1%; consolidated margin at 9.6% — Q1 FY 2026-2027 margins compressed by elevated raw material costs, strategic initiative spend (~0.9%), and warranty provisions.
  • Capex of Rs.450 crores spent in Q1 FY 2026-2027 — against a full-year FY 2026-2027 guided capex of Rs.1,700 crores (Rs.1,300 crores for new energy, balance for lead-acid and recycling).
  • Automotive international revenue declined ~20% YoY — Q1 FY 2026-2027 exports impacted by a volume drop in the Middle East due to costly alternative sea routes; management expects normalcy in coming quarters.
  • AmaronEsis pilot launched in Hyderabad — B2C automotive services pilot commenced in Q1 FY 2026-2027 as part of strategic initiatives.

Pricing actions and operating cost headwinds

  • Raw material costs rose sharply in Q1 FY 2026-2027 — alloys, sulfuric acid, and poly inputs increased; management took a 3% price increase in June 2026, insufficient to fully offset the pressure.
  • Additional 2-3% price hike rolled out in Q2 FY 2026-2027 — management expects full cost recovery by Q3 FY 2026-2027, though B2B price hikes face negotiation delays.
  • ~0.9% sequential hit (~Rs.35 crores) from three initiatives — brand promotion, Amara On Assist pilot, and "factory of the future" debottlenecking treated as revenue expenditure, not capitalised.
  • Other expenses as% of sales above historical ~12.5% level — management expects moderation once one-off initiatives stabilise; freight and warranty costs will ease only when underlying cost drivers improve.
  • Battery breaking recycling plant in trial production — Q1 FY 2026-2027 cost pressure from elevated local scrap prices; plant may improve operating margins once stabilised, though no timeline or quantified impact was provided.
  • Warranty provisioning and freight rose — driven by higher product costs and increased tubular volumes; non-recurring items should normalise over the next two quarters (Q2-Q3 FY 2026-2027).

Lithium cells, BEST, and capacity roadmap

  • Giga 1 (NMC cells) commercialisation in H1 FY 2027-2028 — customer qualification plant inaugurated in July 2026, producing B-samples of 2170 NMC cells; C-sample testing and homologation will follow when gigafactory is ready.
  • Equipment for 2 GWh NMC line ordered — delivery due in Q3 FY 2026-2027; management confirmed the Gotion tie-up did not proceed, but NMC cell technology was successfully internalised and improved in-house.
  • BEST project initial capex guided at Rs.250-Rs.300 crores for 10 GWh LFP capacity — containerised solution pricing at $100-$120; operating margins guided at 5-6% (conservative) to 7-8% (with localization).
  • BESS facility expects 5 GW utilisation within six months of factory completion — line capacity at 10 GWh; management sees sufficient visibility from major Indian EPC players.
  • New energy business supported by >50% volume growth in telecom and three-wheeler packs — Q1 FY 2026-2027 YoY; management prioritising energy storage system (ESS) cells over standard EV cells to accelerate demand uptake.
  • Management evaluating 10 GW PLI tender documents — will participate subject to qualification criteria in FY 2026-2027; LFP cell customer acceptance timelines expected to be substantially lower than for EV customers.
  • No broad-based Chinese tech partnership possible currently — geopolitical restrictions prevent arrangements; new non-Chinese partnerships will be evaluated on a case-to-case basis.

Core battery business and international headwinds

  • FY 2026-2027 lead-acid aftermarket volume guidance — low double-digits for two-wheelers, 7-8% for four-wheelers; management cautioned these may moderate over time due to a large base and EV penetration.
  • Total lead-acid business management forecasts 9-10% revenue growth over the medium term — (period unspecified) driven partly by recovery in international business.
  • Automotive exports declined 20% in volume YoY in Q1 FY 2026-2027 — Middle East shipments affected by costly alternative sea routes; management expects normalcy in coming quarters.
  • UPS batteries grew 10% in Q1 FY 2026-2027 — telecom continues its shift to lithium-ion with offtake substantially higher; other industrial segments (railways, power control) grew 5-6% in line with estimates.
  • Trading revenue contributed 15% of total revenue in Q1 FY 2026-2027 — driven by the tubular season; management indicated this percentage is unlikely to persist as own manufacturing will meet tubular demand in subsequent quarters.

Lithium cell economics, market structure, and capital allocation

  • Indian lithium cell manufacturers face a 15-20% price disadvantage vs. Chinese imports — management noted in Q1 FY 2026-2027 that government protection and deeper domestic supply chains are required to stabilise the industry.
  • Management expects Indian cell manufacturing market to support only 3-4 players — given current announcements, consolidation is anticipated.
  • Initial risk capital of Rs.2,500 crores allocated for the current five facilities — future capex funding decisions (period unspecified) will depend on business case and risk assessment.
  • Lead-acid business generates annual cash of Rs.700-800 crores (post-tax, post-dividend) — providing a funding base for the new energy business for the near term.
  • Initial 16 GWh target by FY30 is not fixed — management stated the "initial target of 16 GWh capacity by FY30" requiring ~Rs.9,000 crores investment will be demand-driven to avoid redundant capacity and financial strain.
  • Strategic direction of 15-20% market share in available lithium cell potential remains intact — though timing may shift; management prioritising ESS over EV cells to accelerate uptake.
  • India depends on China for cathode material procurement — management confirmed no current restrictions on battery cathode/anode materials from China; earlier restrictions (circa October 2025) covered certain core materials and have been delayed by one year.

Guidance, catalysts, and risk factors

  • FY 2026-2027 capex guided at Rs.1,700 crores — Rs.1,300 crores earmarked for new energy, balance for lead-acid and recycling; Rs.450 crores spent in Q1 FY 2026-2027.
  • R&D spend on cell development of ~Rs.100-150 crores in FY 2026-2027 — working capital for the cell business estimated at a cash conversion cycle of 90-100 days based on existing pack business cues.
  • Giga 1 commercialisation in H1 FY 2027-2028; e-positive research facility in Q2 FY 2026-2027 — customer qualification plant already producing B-samples as of July 2026.
  • Andhra Pradesh Pollution Control Board revoked closure order on 18 July 2026 — the order dated 30 April 2021 was withdrawn; company has withdrawn its related writ petition.
  • Management cited government support for localising supply chains and growing domestic energy storage demand — long-term drivers for BEST and cell program expansion, though progress on localisation is not yet mature.
  • Risk: lithium pack revenue booked in standalone entity in Q1 FY 2026-2027 — from upcoming quarters, all substantial lithium trading revenue will be moved to the subsidiary; management declined to provide warranty provisioning estimates for lithium cells, citing the need to wait for commercial data.
Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now